MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development

Identification of novel MDM2 or p53 binding proteins may reveal undefined oncogenes, tumor suppressors, signaling pathways and possible treatment targets.

from Cancer via ola Kala on Inoreader http://ift.tt/2BseNOi
via IFTTT